Condition
Fractures, Bone
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
17 shownAnticholinergic Burden and Osteoporosis in Rheumatoid ArthritisNCT06812481 · 2025-09-15
RECRUITINGVItamin D in pregnanCy for prevenTion Of eaRlY Childhood AsthmaNCT06570889 · 2024-12-20
RECRUITINGFish Oil in pREgnancY for Personalized Prevention of Early Childhood AsthmaNCT06560255 · 2024-12-20
RECRUITINGA Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 InfectionNCT05781581 · 2023-03-19
UNKNOWNMain Postoperative Complications After COVID-19NCT05694949 · 2023-02-01
UNKNOWNLow-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNCT05068180 · 2021-10-05
UNKNOWNEvaluation of The Safety And Performance of The Freedom Total Knee® System With The PEEK-OPTIMA Femoral ComponentNCT03224689 · 2021-01-01
UNKNOWNExperiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare SystemNCT04489992 · 2020-02-21
UNKNOWNDeterminants of Bone and Muscle Quality and Strength in Obesity With and Without DiabetesNCT04093856 · 2020-01-14
COMPLETEDFracture Risk After Pancreas Transplantation (FraPaT)NCT03869281 · 2019-12-07
COMPLETEDSkeletal Effects of Type 1 Diabetes on Low-Trauma Fracture RiskNCT05701254 · 2019-06-18
UNKNOWNBone Marrow Adiposity and Fragility Fractures in Postmenopausal WomenNCT03219125 · 2018-10-16
COMPLETEDBoston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F StudyNCT03414411 · 2018-02-20
COMPLETEDUtilizing Protein During Weight Loss to Impact Physical Function and BoneNCT03819478 · 2017-05-03
COMPLETEDFracture Risk With ThiazolidinedionesNCT01055223 · 2009-05-01
COMPLETEDHow Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups?NCT04359628 · 2002-01-01
UNKNOWNEuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVNCT02699736 · 1994-01-01
ENROLLING_BY_INVITATIONCommon interventions
18-month NutraBio™ 100% Whey Protein Isolate SupplementDIETARY_SUPPLEMENT16-month NutraBio™ 100% Whey Protein Isolate SupplementDIETARY_SUPPLEMENT1Anticholinergic load was calculated using anticholinergic cognitive load (ACB)OTHER1Cholecalciferol D3DIETARY_SUPPLEMENT1Dixon Magnetic Resonance ImagingDEVICE1dual-energy X-ray absorptiometry (DXA)DEVICE1Exercise intervention months 0-6BEHAVIORAL1low-dose neuroleptanalgesiaDRUG1n-3 fatty acidDIETARY_SUPPLEMENT1no interventionOTHER1NutraBio™ CarboMax SupplementDIETARY_SUPPLEMENT1Olive oilOTHER1Pancreas transplantation alonePROCEDURE1PEEK-Optima Femoral ComponentDEVICE1PlaceboDRUG1Rape seed oilOTHER1Transilial bone biopsyPROCEDURE1TZD + amilorideDRUG1TZD + spironolactoneDRUG1TZD only (RSG or PIO or troglitazone)DRUG1Weight loss intervention months 0-6BEHAVIORAL1
Leading sponsors
RenJi Hospital
3
Professor Klaus Bønnelykke
2
Balikesir University
1
Boston University
1
Copenhagen University Hospital, Rigshospitalet
1
Creighton University
1
GlaxoSmithKline
1
Maxx Orthopedics Inc
1
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
1
Suzanne Morin
1
Università Vita-Salute San Raffaele
1
University Hospital, Lille
1
Vastra Gotaland Region
1
Wake Forest University Health Sciences
1
Trial status mix
UNKNOWN7
COMPLETED6
RECRUITING3
ENROLLING_BY_INVITATION1
Phase mix
NA2
PHASE32
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.